142 related articles for article (PubMed ID: 37818158)
1. miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A.
Huang X; Jia Y; Shi H; Fan H; Sun L; Zhang H; Wang Y; Chen J; Han J; Wang M; Du J; Zhang J
Asian Biomed (Res Rev News); 2023 Jun; 17(3):124-135. PubMed ID: 37818158
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of
Tanaka T; Okada R; Hozaka Y; Wada M; Moriya S; Satake S; Idichi T; Kurahara H; Ohtsuka T; Seki N
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977589
[TBL] [Abstract][Full Text] [Related]
3. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
Qi Q; Sun Y; Yang Y; Liu Y
Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
5. Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.
Hajibabaei S; Nafissi N; Azimi Y; Mahdian R; Rahimi-Jamnani F; Valizadeh V; Rafiee MH; Azizi M
Sci Rep; 2023 May; 13(1):8652. PubMed ID: 37244966
[TBL] [Abstract][Full Text] [Related]
6. miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5.
Zhang X; Wang C; Li H; Niu X; Liu X; Pei D; Guo X; Xu X; Li Y
Oncotarget; 2017 Sep; 8(38):64106-64113. PubMed ID: 28969055
[TBL] [Abstract][Full Text] [Related]
7. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
[TBL] [Abstract][Full Text] [Related]
8. RNF144A-AS1, a TGF-β1- and hypoxia-inducible gene that promotes tumor metastasis and proliferation via targeting the miR-30c-2-3p/LOX axis in gastric cancer.
Li Z; Shi L; Li X; Wang X; Wang H; Liu Y
Cell Biosci; 2021 Sep; 11(1):177. PubMed ID: 34583752
[TBL] [Abstract][Full Text] [Related]
9. miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.
Jin L; Li Y; Zhang Z; He T; Hu J; Liu J; Chen M; Gui Y; Yang S; Mao X; Chen Y; Lai Y
Oncol Lett; 2017 Nov; 14(5):5624-5630. PubMed ID: 29113192
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation is induced in renal cell carcinoma through miR-92a-3p upregulation by targeting FBXW7.
Zeng R; Huang J; Sun Y; Luo J
Oncol Lett; 2020 Apr; 19(4):3258-3268. PubMed ID: 32256821
[TBL] [Abstract][Full Text] [Related]
11. miR-30c-5p inhibits glioma proliferation and invasion via targeting Bcl2.
Yuan LQ; Zhang T; Xu L; Han H; Liu SH
Transl Cancer Res; 2021 Jan; 10(1):337-348. PubMed ID: 35116264
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p.
Nguyen HT; Jia W; Beedle AM; Kennedy EJ; Murph MM
PLoS One; 2015; 10(9):e0139489. PubMed ID: 26418018
[TBL] [Abstract][Full Text] [Related]
13. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
[TBL] [Abstract][Full Text] [Related]
14. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
17. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
Huang J; Yao X; Zhang J; Dong B; Chen Q; Xue W; Liu D; Huang Y
Cancer Sci; 2013 Dec; 104(12):1609-17. PubMed ID: 24112779
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
[TBL] [Abstract][Full Text] [Related]
20. SNHG16 promotes cell proliferation and inhibits cell apoptosis via regulation of the miR-1303-p/STARD9 axis in clear cell renal cell carcinoma.
Cheng T; Shuang W; Ye D; Zhang W; Yang Z; Fang W; Xu H; Gu M; Xu W; Guan C
Cell Signal; 2021 Aug; 84():110013. PubMed ID: 33901578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
